A study to test how well different doses of BI 1815368 are tolerated by healthy men

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-503815-13-00

Acronym

1485-0002

Enrollment

Registered

2023-05-30

Start date

2023-06-19

Completion date

2024-06-06

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

None listed

Sex/Gender

Male

Age

18 Years to 64 Years

Belgium

None listed

Source: EU CTIS · Data processed: Feb 4, 2026